Clinical trial for Glomerulonephritis, IGA
Official title Interest of Follicular Helper Lymphocytes / Regulatory Follicular Helper Lymphocytes Ratio in IgA Nephropathy
ClinicalTrials.gov ID: NCT05791162
What this study is testing
- What it's testing
- The study will check whether the balance of two immune cells (Tfh and Tfr) differs in stable versus progressive IgA kidney disease and whether it can forecast how the disease will behave in the first year.
- Who it's for
- People diagnosed with IgA nephropathy.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- IgA nephropathy histologically proven on renal biopsy according to KDIGO criteria, with 8 permeable glomeruli (patients diagnosed from 2009 with a...
- Control patients: Lupus or ANCA-associated vasculitis or polycystic kidney disease (arm 3)
You likely can't join if
- Legal incapacity or limited legal capacity
- people with no social security coverage.
- Pregnancy / No effective contraceptive method
The study team makes the final eligibility decision.
Where it is enrolling
- Besançon, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Besançon, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.